Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | December 31, 2010 | February 11, 2011 |
| EQUITY LIFESTYLE PROPERTIES INCELS · Entity 3434 | Director | April 01, 2024 | April 03, 2024 |
| Rush Street Interactive, Inc.RSI · Entity 2291 | Director | June 10, 2021 | June 11, 2021 |
| SPIRIT REALTY CAPITAL, INC.SRC · Entity 94984 | Director | June 08, 2020 | June 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date December 31, 2010 · Filed February 11, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 127,045.9503 |
Reported balance
Holding disclosure · report date 2010-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 127,045.9503 F1: The purpose to this Form 5 is to correct the share balance in connection with dividend reinvestment shares not previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: The purpose to this Form 5 is to correct the share balance in connection with dividend reinvestment shares not previously reported.
EQUITY LIFESTYLE PROPERTIES INC
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.01SEC Table I · non-derivative | Direct | 743,668 |
Reported balance
After 2024-04-01 transaction · row 1
1 source rowRow 1 · 2024-04-01 · Grant · Acquired 229 · Balance 743,668 F1: Represents shares acquired through ELS' Employee Stock Purchase Plan |
| Common Stock, par value $.01SEC Table I · non-derivative | IndirectBy Spouse | 378,255.28 |
Reported balance
Holding disclosure · report date 2024-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 378,255.28 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares acquired through ELS' Employee Stock Purchase Plan
Rush Street Interactive, Inc.
Report date June 10, 2021 · Filed June 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,710 |
Reported balance
After 2021-06-10 transaction · row 1
1 source rowRow 1 · 2021-06-10 · Grant · Acquired 9,085 · Balance 17,710 F1: On June 10, 2021, the Reporting Person was awarded 9,085 restricted stock units (the "RSUs") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2021, the Reporting Person was awarded 9,085 restricted stock units (the "RSUs") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2022.
SPIRIT REALTY CAPITAL, INC.
Report date June 08, 2020 · Filed June 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.05 per shareSEC Table I · non-derivative | Direct | 18,294 |
Reported balance
After 2020-06-08 transaction · row 1
1 source rowRow 1 · 2020-06-08 · Grant · Acquired 2,754 · Balance 18,294 F1: 2020 Annual Restricted Stock Award for Director service. Restrictions lapse 12 months following the date of grant subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: 2020 Annual Restricted Stock Award for Director service. Restrictions lapse 12 months following the date of grant subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2017 Filed Sep 27, 2017 20:45 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | OtherDepositary Shares | 8,000 | $25.00 | $200,000.00 |
DisclosureSEC source: 0001198222-17-000013 · wf-form4_150654513071105.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each Depositary Share represents 1/100th of a share of the issuer's 6.75% Series C Cumulative Redeemable Perpetual Preferred Stock (the "Series C Preferred Stock"). F2 · kind: The Series C Preferred Stock was redeemed by the issuer on September 25, 2017. In connection with the Series C Preferred Stock redemption, the Depositary Shares were redeemed by the issuer at a price of $25.00 per depositary share. F2 · price: The Series C Preferred Stock was redeemed by the issuer on September 25, 2017. In connection with the Series C Preferred Stock redemption, the Depositary Shares were redeemed by the issuer at a price of $25.00 per depositary share. F2 · acquired: The Series C Preferred Stock was redeemed by the issuer on September 25, 2017. In connection with the Series C Preferred Stock redemption, the Depositary Shares were redeemed by the issuer at a price of $25.00 per depositary share. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 16:36 UTC | SPIRIT REALTY CAPITAL, INC. SRC · Entity 94984 | PurchaseCommon Stock, par value $0.01 per share | 1,000 | $8.27 | $8,270.00 |
DisclosureSEC source: 0001308606-17-000116 · wf-form4_150274261691925.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,280 Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 19:11 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 198 | $71.77 | $14,210.46 |
DisclosureSEC source: 0001198222-17-000011 · wf-form4_149936822480702.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,348 F1 · kind: Represents shares acquired through ELS' Employee Stock Purchase Plan Read SEC document |
| June 28, 2017 Filed Jul 5, 2017 16:14 UTC | SPIRIT REALTY CAPITAL, INC. SRC · Entity 94984 | GrantCommon Stock, par value $0.01 per share | 11,185 | $7.60 | $85,006.00 |
DisclosureSEC source: 0001308606-17-000103 · wf-form4_149928562942048.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,280 F1 · shares: 2017 Annual Restricted Stock Award for Director service. Restrictions lapse 12 months following date of grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 22:19 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 493 | $81.15 | $40,006.95 |
DisclosureSEC source: 0001198222-17-000009 · wf-form4_149393638168046.xml · nonDerivative · entry 4 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,150 F3 · kind: Grant of restricted stock subject to vesting as follows: 1/3 on 5/2/18, 1/3 on 5/2/19, and 1/3 on 5/2/20 Read SEC document |
| May 02, 2017 Filed May 4, 2017 22:19 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 246 | $81.15 | $19,962.90 |
DisclosureSEC source: 0001198222-17-000009 · wf-form4_149393638168046.xml · nonDerivative · entry 3 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,657 F3 · kind: Grant of restricted stock subject to vesting as follows: 1/3 on 5/2/18, 1/3 on 5/2/19, and 1/3 on 5/2/20 Read SEC document |
| May 02, 2017 Filed May 4, 2017 22:19 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 92 | $81.15 | $7,465.80 |
DisclosureSEC source: 0001198222-17-000009 · wf-form4_149393638168046.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,411 F2 · kind: Grant of restricted stock subject to vesting on 5/2/18 Read SEC document |
| May 02, 2017 Filed May 4, 2017 22:19 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 1,232 | $81.15 | $99,976.80 |
DisclosureSEC source: 0001198222-17-000009 · wf-form4_149393638168046.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,319 F1 · kind: Grant of restricted stock subject to vest as follows: 1/3 on 11/2/17, 1/3 on 5/2/18, and 1/3 on 5/2/19 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:39 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 218 | $65.50 | $14,279.00 |
DisclosureSEC source: 0001198222-17-000007 · wf-form4_149133836881976.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,087 F1 · kind: Represents shares acquired through ELS' Employee Stock Purchase Plan Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 22:34 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | SaleCommon Stock, par value $.01 | 12,000 | $78.29 | $939,420.00 |
DisclosureSEC source: 0001198222-17-000005 · wf-form4_148823485047713.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 189,127.64 Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 19:30 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 243 | $58.72 | $14,268.96 |
DisclosureSEC source: 0001198222-17-000003 · wf-form4_148364460032197.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,869 F1 · kind: Represents shares acquired through ELS' Employee Stock Purchase Plan Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:52 UTC | EQUITY LIFESTYLE PROPERTIES INC ELS · Entity 3434 | GrantCommon Stock, par value $.01 | 217 | $65.60 | $14,235.20 |
DisclosureSEC source: 0000895417-16-000119 · wf-form4_147570072015291.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,626 F1 · kind: Represents shares acquired through ELS' Employee Stock Purchase Plan Read SEC document |
| November 04, 2010 Filed Nov 5, 2010 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-027154 · form4.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,112.4607 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| May 12, 2010 Filed May 14, 2010 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-014362 · form4.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,828.4607 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| November 04, 2009 Filed Nov 6, 2009 21:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,734 | $36.15 | $134,984.10 |
DisclosureSEC source: 0001127602-09-022022 · form4.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,112.4607 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| May 06, 2009 Filed May 8, 2009 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,224 | $31.96 | $134,999.04 |
DisclosureSEC source: 0001127602-09-010997 · form4.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,473.1535 F1 · shares: Consists of common stock acquired as semi-annual compensation. Read SEC document |
| November 05, 2008 Filed Nov 7, 2008 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,399 | $30.69 | $135,005.31 |
DisclosureSEC source: 0001127602-08-008967 · form4.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,154.4607 F2 · shares: Consists of common stock acquired as an annual grant, semi-annual compensation and/or meeting fees. Read SEC document |
| May 07, 2008 Filed May 8, 2008 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,250 | $41.53 | $301,092.50 |
DisclosureSEC source: 0000064803-08-000060 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,859.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 05, 2008 Filed Mar 6, 2008 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 73 | $40.28 | $2,940.44 |
DisclosureSEC source: 0000064803-08-000038 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,609.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| February 12, 2008 Filed Feb 13, 2008 21:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 48 | $40.36 | $1,937.28 |
DisclosureSEC source: 0000064803-08-000016 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,512.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 09, 2008 Filed Jan 10, 2008 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 105 | $37.19 | $3,904.95 |
DisclosureSEC source: 0000064803-08-000008 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,464.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 08, 2008 Filed Jan 10, 2008 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 53 | $37.53 | $1,989.09 |
DisclosureSEC source: 0000064803-08-000008 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,359.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 21:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 852 | $41.64 | $35,477.28 |
DisclosureSEC source: 0000064803-07-000171 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,306.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000171 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,454.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000162 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,136 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 76 | $39.19 | $2,978.44 |
DisclosureSEC source: 0000064803-07-000155 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,113 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| July 11, 2007 Filed Jul 12, 2007 20:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.18 | $976.86 |
DisclosureSEC source: 0000064803-07-000138 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,037 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| June 26, 2007 Filed Jun 27, 2007 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $35.86 | $968.22 |
DisclosureSEC source: 0000064803-07-000130 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,010 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| June 25, 2007 Filed Jun 27, 2007 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.31 | $980.37 |
DisclosureSEC source: 0000064803-07-000130 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,983 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| June 14, 2007 Filed Jun 15, 2007 18:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 26 | $37.26 | $968.76 |
DisclosureSEC source: 0000064803-07-000122 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,956 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 09, 2007 Filed May 10, 2007 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,116 | $38.02 | $194,510.32 |
DisclosureSEC source: 0000064803-07-000106 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,930 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| April 03, 2007 Filed Apr 4, 2007 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0000064803-07-000076 · doc.xml · derivative · entry 3 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 01/02/03. Read SEC document |
| April 03, 2007 Filed Apr 4, 2007 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 30,000 | $14.96 | $448,875.00 |
DisclosureSEC source: 0000064803-07-000076 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 28, 2007 Filed Mar 29, 2007 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 29 | $33.95 | $984.55 |
DisclosureSEC source: 0000064803-07-000075 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,814 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 19, 2007 Filed Mar 20, 2007 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 30 | $33.14 | $994.20 |
DisclosureSEC source: 0000064803-07-000048 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,785 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 07, 2007 Filed Mar 8, 2007 21:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 94 | $31.32 | $2,944.08 |
DisclosureSEC source: 0000064803-07-000044 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,755 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 21:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 31 | $31.30 | $970.30 |
DisclosureSEC source: 0000064803-07-000044 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,661 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 60 | $32.65 | $1,959.00 |
DisclosureSEC source: 0000064803-07-000027 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,630 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| February 06, 2007 Filed Feb 7, 2007 21:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 30 | $33.16 | $994.80 |
DisclosureSEC source: 0000064803-07-000021 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,570 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 16, 2007 Filed Jan 17, 2007 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 31 | $31.88 | $988.13 |
DisclosureSEC source: 0000064803-07-000012 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,540 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 10, 2007 Filed Jan 11, 2007 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 128 | $31.01 | $3,968.64 |
DisclosureSEC source: 0000064803-07-000007 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,509 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 09, 2007 Filed Jan 11, 2007 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 64 | $31.11 | $1,991.04 |
DisclosureSEC source: 0000064803-07-000007 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,381 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 22, 2006 Filed Dec 27, 2006 16:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 31 | $31.46 | $975.11 |
DisclosureSEC source: 0000064803-06-000053 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,244 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 09, 2006 Filed Nov 13, 2006 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 558 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-06-000040 · doc.xml · derivative · entry 3 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,076 Underlying: Common Stock · 558 shares Expires not disclosed F3 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F4 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F4 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 09, 2006 Filed Nov 13, 2006 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 625 | $29.14 | $18,212.50 |
DisclosureSEC source: 0000064803-06-000040 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,916 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 08, 2006 Filed Nov 13, 2006 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 33 | $29.81 | $983.57 |
DisclosureSEC source: 0000064803-06-000040 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,291 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 01, 2006 Filed Nov 2, 2006 19:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 34 | $29.19 | $992.46 |
DisclosureSEC source: 0000064803-06-000033 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,258 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| October 23, 2006 Filed Oct 25, 2006 14:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 96 | $31.03 | $2,978.40 |
DisclosureSEC source: 0000064803-06-000024 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,224 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 20, 2006 Filed Sep 22, 2006 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 84 | $35.20 | $2,956.38 |
DisclosureSEC source: 0000064803-06-000013 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,128 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| July 06, 2006 Filed Jul 10, 2006 16:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 33 | $30.11 | $993.63 |
DisclosureSEC source: 0001174477-06-000007 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,044 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.